Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06266533 · ClinicalTrials.gov registry record · NA

Dismantling the U.S. Social Norm of the "Kids' Food" Archetype (REACH Project)

A NA study, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT06266533: Completed NA study, sponsored by Rutgers, The State University of New Jersey.

NCT06266533 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06266533, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

This project is the first stage of a health promotion campaign to shift social norms about marketing and feeding children ultra-processed foods. Embedded within a longitudinal ethnographic study using photo-elicitation techniques, mothers of preschool-age children will be randomly assigned to arts-based or traditional education about ultra-processed food.

Primary Outcome

Participants will classify pictures of foods as ultra-processed or whole foods (adapted from Sarmiento-Santos, cited below) and as healthy or unhealthy. on a Pre and post-ultra-processed food knowledge questionnaire. Both sets of questions are yes or no categorical questions.

Interventions

  • BEHAVIORAL Conventional Ultra-processed Food Nutrition Education
  • BEHAVIORAL Arts-based Ultra-processed Food Nutrition Education

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2024-02-21
Est. Completion 2024-07-01
Phase NA

What the finished NCT06266533 record still lists

NCT06266533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Conventional Ultra-processed Food Nutrition Education is the first listed.

NCT06266533 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06266533 about?

NCT06266533 is a clinical study titled "Dismantling the U.S. Social Norm of the "Kids' Food" Archetype (REACH Project)". This project is the first stage of a health promotion campaign to shift social norms about marketing and feeding children ultra-processed foods. Embedded within a longitudinal ethnographic study using photo-elicitation techniques, mothers of preschool-age children will be randomly assigned to arts-b...

What is the current status of trial NCT06266533?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2024-02-21. Estimated completion is 2024-07-01.

What interventions are being tested in trial NCT06266533?

The interventions under investigation include: Conventional Ultra-processed Food Nutrition Education (BEHAVIORAL), Arts-based Ultra-processed Food Nutrition Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06266533?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06266533's enrollment target sits among peer trials

38 1538th of 2000 higher than 461 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01684904 · 38 participants · NA

    Proton Therapy for Esophageal Cancer

  • NCT03310879 · 38 participants · Phase 2

    Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6

  • NCT03896269 · 38 participants · Phase 1

    CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

  • NCT04085315 · 38 participants · Phase 1

    Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06266533, the US trial registry maintained by the National Library of Medicine. NCT06266533 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.